Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Change in Cash (2017 - 2025)

Historic Change in Cash for Sensus Healthcare (SRTS) over the last 9 years, with Q3 2025 value amounting to $2.3 million.

  • Sensus Healthcare's Change in Cash fell 3611.27% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 849.83%. This contributed to the annual value of -$1.1 million for FY2024, which is 5396.29% up from last year.
  • According to the latest figures from Q3 2025, Sensus Healthcare's Change in Cash is $2.3 million, which was down 3611.27% from $3.1 million recorded in Q2 2025.
  • In the past 5 years, Sensus Healthcare's Change in Cash registered a high of $18.3 million during Q1 2022, and its lowest value of -$12.1 million during Q4 2022.
  • For the 5-year period, Sensus Healthcare's Change in Cash averaged around $502421.1, with its median value being $873000.0 (2022).
  • Data for Sensus Healthcare's Change in Cash shows a peak YoY increase of 155904.38% (in 2022) and a maximum YoY decrease of 54407.05% (in 2022) over the last 5 years.
  • Over the past 5 years, Sensus Healthcare's Change in Cash (Quarter) stood at -$1.9 million in 2021, then plummeted by 544.07% to -$12.1 million in 2022, then surged by 122.07% to $2.7 million in 2023, then tumbled by 118.87% to -$502000.0 in 2024, then skyrocketed by 556.37% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $3.1 million for Q2 2025, and -$3.0 million during Q1 2025.